NASDAQ: TBIO       Translate Bio Inc
Last Price Today's Change   Day's Range   Trading Volume
13.38   +0.06 (0.45%)  13.02 - 13.73  163,663


Avg Volume (4 weeks):945,510
4 Weeks Range:12.555 - 16.15
4 Weeks Price Volatility (%):
52 Weeks Range:6.80 - 28.09
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Transgenomic, Inc. is a biotechnology company. The Company is engaged in advancing personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services. The Company operates through its Laboratory Services segment. The Company is engaged in the provision of its Multiplexed ICE COLD-PCR (MX-ICP) product to the clinical market, enabling the use of blood and other bodily fluids for diagnosis, monitoring and treatment of cancer. MX-ICP amplifies the ability to detect genetic mutations by approximately 100 to 400 fold. MX-ICP is validated internally on sequencing platforms, including Sanger, Next Gen Sequencing and Digital polymerase chain reaction (PCR). Its laboratory in Omaha, Nebraska is focused on providing genetic analytical services related to oncology and pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical and biotechnology companies.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2200  3606  437  3145 

Top 10 Active Counters
 LK 1.38+1.38 
 AMD 80.405-1.825 
 ISIG 1.25+0.304 
 OAS 0.155-0.014 
 NIO 27.22+1.21 
 AMTD 39.97-0.85 
 PGNX 4.10-0.425 
 AAPL 116.615+1.565 
 SNAP 41.51+0.24 
 XOG 0.271-0.062